Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity

Journal of Affective Disorders

Volumn 87, Issue 2-3, 2005, Pages 305-311

  Kaestner, Florian ^a   Hettich, Michael ^a   Peters, Marion ^a   Sibrowski, Walter ^a   Hetzel, Günter ^a   Ponath, Gerald ^a   Arolt, Volker ^a   Cassens, Uwe ^a   Rothermundt, Matthias ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Cytokine receptors; Cytokines; Depressive disorder; Etiology; Glucocorticoids; Melancholic subtype

Indexed keywords

CORTICOTROPIN; CYTOKINE; HYDROCORTISONE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; MITOGENIC AGENT;

ADULT; ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MAJOR DEPRESSION; MALE; MELANCHOLIA; PRIORITY JOURNAL; REMISSION; SAMPLE SIZE; STANDARDIZATION; STATISTICAL SIGNIFICANCE; SYMPTOM;

ADRENOCORTICOTROPIC HORMONE; CYTOKINES; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INTERLEUKIN-1; MALE; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; RECEPTORS, INTERLEUKIN-1;

EID: 22844435863     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2005.03.012     Document Type: Article

References (41)

1. H. Anisman, and Z. Merali Cytokines, stress and depressive illness: brain-immune interactions Ann. Med. 35 2003 2 11
2. W.P. Arend The balance between IL-1 and IL-1Ra in disease Cytokine Growth Factor Rev. 13 2002 323 340
3. F. Brambilla, and M. Maggioni Blood levels of cytokines in elderly patients with major depressive disorder Acta Psychiatr. Scand. 97 1998 309 313
4. M. Carney, M. Roth, and R. Garside The diagnosis of depressive syndromes and the prediction of E.C.T. response Br. J. Psychiatry 111 1965 659 674
5. P. Cosyns, M. Maes, M. Vandewoude, W.J. Stevens, L.S. De Clerck, and C. Schotte Impaired mitogen-induced lymphocyte responses and the hypothalamic-pituitary-adrenal axis in depressive disorders J. Affect. Disord. 16 1989 41 48
6. R. Dantzer, E.E. Wollman, L. Vitkovic, and R. Yirmiya Cytokines, stress, and depression Adv. Exp. Med. Biol. 461 1999 317 329
7. B.A. De Jong, T.W. Huizinga, E.L. Bollen, B.M. Uitdehaag, G.P. Bosma, M.A. van Buchem, E.J. Remarque, A.C. Burgmans, N.F. Kalkers, C.H. Polman, and R.G. Westendorp Production of IL-1beta and IL-1Ra as risk factors for susceptibility and progression of relapse-onset multiple sclerosis J. Neuroimmunol. 126 2002 172 179
8. J. Griffiths, A.V. Ravindran, Z. Merali, and H. Anisman Immune and behavioral correlates of typical and atypical depression Abstr.-Soc. Neurosci. 22 1996 1350
9. H. Kirchner, C. Kleinicke, and W. Digel A whole-blood technique for testing production of human interferon by leukocytes J. Immunol. Methods 48 1982 213 219
10. Z. Kronfrol Immune dysregulation in major depression: a critical review of exciting evidence Int. J. Neuropsychopharmacol. 5 2002 333 343
11. M. Kubera, G. Kenis, E. Bosmans, A. Zieba, D. Dudek, G. Nowak, and M. Maes Plasma levels of interleukin-6, interleukin-10, and interleukin-1 receptor antagonist in depression: comparison between the acute state and after remission Pol. J. Pharmacol. 52 2000 237 241
12. B.E. Leonard The immune system, depression and the action of antidepressants Prog. Neuro-Psychopharmacol. Biol. Psychiatry 25 2001 767 780
13. B.E. Leonard, and C. Song Stress, depression, and the role of cytokines Adv. Exp. Med. Biol. 461 1999 251 265
14. J. Licinio, and P. Frost The neuroimmune-endocrine axis: pathophysiological implications for the central nervous system cytokines and hypothalamus-pituitary-adrenal hormone dynamics Braz. J. Med. Biol. Res. 33 2000 1141 1148
15. M. Maes, E. Bosmans, E. Suy, B. Minner, and J. Raus Impaired lymphocyte stimulation by mitogens in severely depressed patients. A complex interface with HPA-axis hyperfunction, noradrenergic activity and the ageing process Br. J. Psychiatry 155 1989 793 798
16. M. Maes, E. Bosmans, H.Y. Meltzer, S. Scharpe, and S. Suy Interleukin-1β: a putative mediator of HPA axis hyperactivity in major depression? Am. J. Psychiatry 150 1993 1189 1193
17. M. Maes, E. Vandoolaeghe, R. Ranjan, E. Bosmans, R. Bergmans, and R. Desnyder Increased serum interleukin-1-receptor-antagonist concentration in major depression J. Affect. Disord. 36 1995 29 36
18. M. Maes, E. Bosmans, R. De Jongh, G. Kenis, E. Vandoolaeghe, and H. Neels Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression Cytokine 9 1997 853 858
19. M. Maes, C. Song, A. Lin, S. Bonaccorso, S. Scharpe, G. Kenis, R. DeJongh, E. Bosmans, and S. Sharpe Negative immunoregulatory effects of antidepressants: increased production of interleukin-10 and suppressed production of interferon-gamma Neuropsychopharmacology 20 1999 370 379
20. S.A. Montgomery, and M. Asberg A new depression scale designed to be sensitive to change Br. J. Psychiatry 134 1979 382 389
21. B.H. Natelson, T.N. Denny, X.D. Zhou, J.J. LaManca, J.E. Ottenweller, L. Tiersky, J. DeLuca, and W.C. Gause Is depression associated with immune activation? J. Affect. Disord. 53 1999 179 184
22. A.B. Negrao, J. Licinio, M.L. Wong, P. Bongiorno, T.D. Geracioti, P.W. Gold, and M. Kling Cytokine levels in major depressive disorder Abstr.-Soc. Neurosci. 22 1996 1350
23. M.G. Netea, N. Hancu, W.L. Blok, P. Grigorescu-Sido, L. Popa, V. Popa, and J.W. van der Meer Interleukin 1 beta, tumour necrosis factor-alpha and interleukin 1 receptor antagonist in newly diagnosed insulin-dependent diabetes mellitus: comparison to long-standing diabetes and healthy individuals Cytokine 9 1997 284 287
24. N.U. Neumann, and R.M. Schulte MADR-Skala zur psychometrischen Beurteilung depressiver Symptome (MADRS) 1989 Perimed Erlangen
25. S.M. O'Brien, L.V. Scott, and T.G. Dinan Cytokines: abnormalities in major depression and implications for pharmacological treatment Hum. Psychopharmacol. 19 2004 397 403
26. T.M. O'Connor, D.J. O'Halloran, and F. Shanahan The stress response and the hypothalamic-pituitary-adrenal axis: from molecule to melancholica Q. J. Med. 93 2000 323 333
27. B.M. Owen, D. Eccleston, I.N. Ferrier, and A.H. Young Raised levels of plasma interleukin-1β in major and postviral depression Acta Psychiatr. Scand. 103 2001 226 228
28. D. Refojo, A.C. Liberman, F. Holsboer, and E. Arzt Transcriptional factor-mediated molecular mechanisms involved in the functional cross-talk between cytokines and glucocorticoids Immunol. Cell Biol. 79 2001 385 394
29. M. Rothermundt, V. Arolt, M. Peters, H. Gutbrodt, J. Fenker, A. Kersting, and H. Kirchner Inflammatory markers in major depression and melancholia J. Affect. Disord. 63 2001 93 102
30. M. Rothermundt, V. Arolt, J. Fenker, H. Gutbrodt, M. Peters, and H. Kirchner Different immune patterns in melancholic and non-melancholic major depression Eur. Arch. Psychiatry Clin. Neurosci. 251 2001 90 97
31. J. Schlatter, F. Ortuno, and S. Cervera-Enguix Differences in interleukins' patterns between dysthymia and major depression Eur. Psychiatr. 16 2001 317 319
32. A. Seidel, V. Arolt, M. Hunstiger, L. Rink, A. Behnisch, and H. Kirchner Cytokine production and serum proteins in depression Scand. J. Immunol. 41 1995 534 538
33. M. Seitz, M. Zwicker, and P.M. Villiger Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different American College of Rheumatology response groups to methotrexate J. Rheumatol. 30 2003 28 35
34. K.D. Sekiyama, M. Yoshiba, and A.W. Thomson Circulating proinflammatory cytokines (IL-1 beta, TNF-alpha, and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitis Clin. Exp. Immunol. 98 1994 71 77
35. M. Shingu, Y. Fujikawa, T. Wada, S. Nonaka, and M. Nobunaga Increased IL-1 receptor antagonist (IL-1ra) production and decreased IL-1 beta/IL-1ra ratio in mononuclear cells from rheumatoid arthritis patients Br. J. Rheumatol. 34 1995 24 30
36. A. Sluzewska, J.K. Rybakowski, M. Laciak, A. Mackiewicz, M. Sobieska, and K. Wiktorowicz Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine Ann. N.Y. Acad. Sci. 762 1995 474 476
37. C. Song, A. Lin, S. Bonaccorso, C. Heide, R. Verkerk, G. Kenis, E. Bosmans, S. Scharpe, A. Whelan, P. Cosyns, R. de Jongh, and M. Maes The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression J. Affect. Disord. 49 1998 211 219
38. A. Ströhle, and F. Holsboer Stress responsive neurohormones in depression and anxiety Pharmacopsychiatry 36 Suppl. 3 2003 S207 S214
39. D. Van West, and M. Maes Activation of the inflammatory response system: a new look at the etiopathogensis of major depression Neuro-endocrinol. Lett. 20 1999 11 17
40. R. Weizman, N. Laor, E. Podliszewski, I. Notti, M. Djaldetti, and H. Bessler Cytokine production in major depressed patients before and after clomipramine treatment Biol. Psychiatry 35 1994 42 47
41. H.U. Wittchen, M. Zaudig, and T. Fydrich Strukturiertes Klinisches Interview für DSM-IV Achse I und II (SKID-I und SKID-II) 1997 Hogrefe Göttingen